Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g 4 Regulatory News (MAV4)

Share Price Information for Maven I&g 4 (MAV4)

Share Price is delayed by 15 minutes
Get Live Data
50.00    0.00 (0.00%)
Bid:
49.00
Ask:
51.00
Spread: 2.00 (4.082%)
Market Cap: £83.71m
MAV4 Live PriceLast checked at - London Stock Exchange

Intraday Maven I&g 4 Share Chart

Replacement Statement re Listing Application

18 Oct 2017 10:43

RNS Number : 9484T
Maven Income & Growth VCT 4 PLC
18 October 2017
 

 

Maven Income and Growth VCT 4 PLC (the Company) - Statement re Listing Application

 

 

The issuer advises that the following replaces the Maven Income and Growth VCT 4 PLC - Statement re Listing Application announcement released at 14:49 BST on 17 October 2017.

 

The details under the first bullet point should be:

 

· Resolution 1 to: (i) authorise the directors to allot 804,028 new S ordinary shares pursuant to the share consolidation; (ii) redesignate 6,068,474 S ordinary shares of 10p each ("S Shares") as an ordinary share of 10p each ("Ordinary Shares") and (iii) amend the articles of association of the Company to remove any reference to S Shares as a separate class of shares - 97.59% of proxy votes received being in favour (or at the chairman's discretion);

The second paragraph under "Share Consolidation" should read:

Pursuant to Resolution 1 which was passed at the general meeting, immediately following the admission of such new S Shares to the Official List, all 6,068,474 of the S Shares then in issue in the capital of the Company will be redesignated as Ordinary Shares on a ratio of one to one. As a result, following completion of the Share Consolidation, holders of S Shares will hold 1.1528 Ordinary Shares for every S Share held on the record date for the Share Consolidation.

 

All other details remain unchanged.

 

The full amended version is shown below

 

 

Maven Income and Growth VCT 4 PLC (the Company) - Statement re Listing Application

 

 

The Announcement below was originally released on 26 March 2013, however admission did not take place. The shares will now formally be admitted on 19 October 2017.

 

 

Maven Income and Growth VCT 4 PLC

 

Results of Shareholder Meetings and Share Capital Consolidation

 

26 March 2013

 

This announcement is made by Maven Income and Growth VCT 4 PLC ("the Company") in connection with (i) the proposed consolidation of its share capital ("Share Consolidation") and (ii) the proposed merger of the Company with Ortus VCT PLC ("Ortus"), which will be completed pursuant to a scheme of reconstruction under Section 110 of the Insolvency Act 1986 whereby Ortus will transfer all of its assets and liabilities to the Company in consideration of shares being issued by the Company ("the Scheme"), details of which were contained in the Company's circular to shareholders ("Circular") and prospectus ("Prospectus") both dated 1 March 2013.

 

Results of the General Meeting and Class Meetings

 

The Board is pleased to announce that at the general meeting and class meetings of the Company held on 26 March 2013, the resolutions proposed in connection with the Share Consolidation and the Scheme and other matters, as set out in the Circular, were duly passed on a show of hands.

 

Details of the resolutions passed at the general meeting are as follows:

 

· Resolution 1 to: (i) authorise the directors to allot 804,028 shares pursuant to the share consolidation; (ii) redesignate 6,068,474 S ordinary shares of 10p each ("S Shares") as an ordinary share of 10p each ("Ordinary Shares") and (iii) amend the articles of association of the Company to remove any reference to S Shares as a separate class of shares - 97.59% of proxy votes received being in favour (or at the chairman's discretion);

· Resolution 2 to: (i) approve the acquisition of all of the assets and liabilities of Ortus VCT PLC; (ii) amend the articles of association of the Company to provide for the rights attaching to, and the conversion of, C ordinary shares; (iii) authorise the directors to allot shares pursuant to the Scheme and (iv) authorise the buyback of deferred shares - 96.49% of proxy votes received being in favour (or at the chairman's discretion);

· Resolution 3 to approve a change to the investment policy as detailed in Part V of the Circular - 98.91% of proxy votes received being in favour (or at the chairman's discretion);

· Resolution 4 to: (i) authorise the directors to allot shares; (ii) disapply pre-emption rights and (iii) authorise the Company to make market purchases of shares - 98.74% of proxy votes received being in favour (or at the chairman's discretion);

· Resolution 5 to: (i) authorise the cancellation of the amount standing to the credit of the share premium account as at the date an order is made the court and (ii) authorise the cancellation of the amount standing to the credit of the capital redemption reserve as at the date an order is made the court - 100% of proxy votes received being in favour (or at the chairman's discretion).

The resolutions passed at the Ordinary Share class meeting approved the passing of Resolution 1 and 2 at the general meeting and sanction any modification of the rights of the Ordinary Shares resulting therefrom - 97.06% and 97.06% of proxy votes received being in favour (or at the chairman's discretion), respectively.

 

The resolutions passed at the S Share class meeting approved the passing of Resolution 1 and 2 at the general meeting and sanction any modification of the rights of the S Shares resulting therefrom - 81.80% and 81.80% of proxy votes received being in favour (or at the chairman's discretion), respectively.

 

A copy of the resolutions passed at the meetings will shortly be available for inspection on both the Company's website (www.mavencp.com) as well as at the National Storage Mechanism (www.morningstar.co.uk/uk/NSM).

 

 

Share Consolidation

 

Pursuant to the Share Consolidation, 804,028 new S Shares have been issued today to the holders of S Shares on the Company's register on 25 March 2013 (this being the record date for the Share Consolidation). Application has been made to the UK Listing Authority for such shares to be admitted to the premium segment of the Official List, which is expected to take place on 27 March 2013.

 

Pursuant to Resolution 1 which was passed at the general meeting, immediately following the admission of such new S Shares to the Official List, all 6,068,474 of the S Shares then in issue in the capital of the Company will be redesignated as Ordinary Shares on a ratio of one to one. As a result, following completion of the Share Consolidation, holders of S Shares will hold 1.1528 Ordinary Shares for every S Share held on the record date for the Share Consolidation.

 

Applications will be made to the UK Listing Authority and London Stock Exchange in connection with the listing and admission of the new Ordinary Shares resulting from the Share Consolidation (and cancellation of the S Shares listing) which is expected to take effect on 28 March 2013. CREST accounts of shareholders who hold their Shares in CREST are expected to be updated and re-credited by 28 March 2013, with replacement share certificates dispatched to those who hold their share in certificated form expected to take place on 10 April 2013.

 

Following completion of the Share Consolidation, 15,225,880 Shares will be in issue. Therefore, the total number of voting rights in the Company will be 15,225,880, which may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or change to their interest in, the Company under the FSA's Disclosure and Transparency Rules.

 

Please note, as a result of subsequent share issues and buy-backs, the Company confirms that its issued share capital as at 17 October 2017 comprises 32,704,925 Ordinary Shares, with each share carrying one voting right.

 

 

For further enquiries please contact:

 

Maven Capital Partners UK LLP

0141 306 7400

enquries@mavencp.com 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRFMMMGLRLGNZG
Date   Source Headline
20th May 202610:12 amRNSAdmission of Further Securities to Trading
15th May 202610:45 amRNSDirector/PDMR Shareholding
15th May 202610:41 amRNSIssue of Equity - Dividend Investment Scheme
14th May 20265:22 pmRNSTransaction in Own Shares
12th May 20263:37 pmRNSUnaudited NAV - Dividend Investment Scheme
7th May 20261:45 pmRNSResult of AGM
30th Apr 202610:58 amRNSAdmission of Further Securities to Trading
29th Apr 202612:29 pmRNSIssue of Equity
20th Apr 202612:23 pmRNSPublication of a Supplementary Prospectus
15th Apr 202611:27 amRNSAdmission of Further Securities to Trading
14th Apr 202611:09 amRNSIssue of Equity
10th Apr 202612:02 pmRNSUnaudited Net Asset Value
8th Apr 20269:33 amRNSAdmission of Further Securities to Trading
25th Mar 20263:51 pmRNSTransaction in Own Shares
25th Mar 202610:55 amRNSAdmission of Further Securities to Trading
24th Mar 202612:11 pmRNSIssue of Equity
19th Mar 20264:21 pmRNSUnaudited NAV and Proposed Final Dividend
18th Feb 20264:58 pmRNSAdmission of Further Securities to Trading
17th Feb 202611:07 amRNSDirector/PDMR Shareholding
17th Feb 202611:07 amRNSDirector/PDMR Shareholding
17th Feb 202610:54 amRNSIssue of Equity
4th Feb 20267:00 amRNSStatement re Offer for Subscription
21st Jan 202611:07 amRNSAdmission of Further Securities to Trading
20th Jan 20262:05 pmRNSAdmission of Further Securities to Trading
16th Jan 20269:52 amRNSDirector/PDMR Shareholding
16th Jan 20269:44 amRNSIssue of Equity
15th Jan 202610:36 amRNSDirector/PDMR Shareholding
15th Jan 202610:35 amRNSDirector/PDMR Shareholding
15th Jan 20269:55 amRNSIssue of Equity
14th Jan 20262:39 pmRNSUnaudited NAV - Dividend Investment Scheme
13th Jan 202612:10 pmRNSUnaudited Net Asset Value
4th Dec 202510:35 amRNSSecond Interim Dividend
18th Nov 20253:48 pmRNSTransaction in Own Shares
14th Nov 20259:31 amRNSNet Asset Value(s)
13th Nov 20254:53 pmRNSResult of General Meeting
2nd Oct 20254:42 pmRNSPublication of a Prospectus
29th Aug 20257:00 amRNSDirector/PDMR Shareholding
29th Aug 20257:00 amRNSIssue of Equity
29th Aug 20257:00 amRNSHalf-year Report
20th Aug 20252:14 pmRNSStatement re Dividend Investment Scheme
31st Jul 20254:42 pmRNSTransaction in Own Shares
16th Jul 202510:18 amRNSStatement re Unaudited NAV and Interim Dividend
16th Jul 20257:08 amRNSStatement re Offer for Subscription
21st May 20254:44 pmRNSTransaction in Own Shares
16th May 20259:30 amRNSDirector/PDMR Shareholding
16th May 20259:26 amRNSIssue of Equity - Dividend Investment Scheme
9th May 20251:53 pmRNSStatement re Dividend Investment Scheme
9th May 202510:03 amRNSNet Asset Value(s)
8th May 20251:43 pmRNSResult of AGM
6th May 202511:55 amRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.